-DOCSTART- -X- O
Neuromyelitis -X- _ B-Patient
optica -X- _ I-Patient
( -X- _ I-Patient
NMO -X- _ I-Patient
) -X- _ I-Patient
is -X- _ O
an -X- _ O
inflammatory -X- _ O
disease -X- _ O
characterized -X- _ O
by -X- _ O
recurrent -X- _ O
attacks -X- _ O
of -X- _ O
optic -X- _ O
neuritis -X- _ O
and -X- _ O
myelitis. -X- _ O
It -X- _ O
is -X- _ O
generally -X- _ O
accepted -X- _ O
that -X- _ O
autoantibodies -X- _ O
against -X- _ O
aquaporin -X- _ O
4 -X- _ O
water -X- _ O
channel -X- _ O
protein -X- _ O
play -X- _ O
a -X- _ O
pathogenic -X- _ O
role -X- _ O
in -X- _ O
neuromyelitis -X- _ O
optica. -X- _ O
We -X- _ O
have -X- _ O
recently -X- _ O
reported -X- _ O
that -X- _ O
plasmablasts -X- _ B-Outcome
are -X- _ I-Outcome
increased -X- _ I-Outcome
in -X- _ O
the -X- _ O
peripheral -X- _ O
blood -X- _ O
of -X- _ O
this -X- _ O
autoimmune -X- _ O
disease -X- _ O
, -X- _ O
and -X- _ O
are -X- _ O
capable -X- _ O
of -X- _ O
producing -X- _ O
autoantibodies -X- _ O
against -X- _ O
aquaporin -X- _ O
4. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
demonstrate -X- _ O
that -X- _ O
CD138 -X- _ B-Outcome
( -X- _ I-Outcome
+ -X- _ I-Outcome
) -X- _ I-Outcome
HLA-DR -X- _ I-Outcome
( -X- _ I-Outcome
+ -X- _ I-Outcome
) -X- _ I-Outcome
plasmablasts -X- _ I-Outcome
, -X- _ I-Outcome
a -X- _ I-Outcome
subset -X- _ I-Outcome
of -X- _ I-Outcome
IgG-producing -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
are -X- _ I-Outcome
increased -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
peripheral -X- _ I-Outcome
blood -X- _ I-Outcome
and -X- _ I-Outcome
are -X- _ I-Outcome
enriched -X- _ I-Outcome
among -X- _ I-Outcome
the -X- _ I-Outcome
cerebrospinal -X- _ I-Outcome
fluid -X- _ I-Outcome
( -X- _ I-Outcome
CSF -X- _ I-Outcome
) -X- _ I-Outcome
lymphocytes -X- _ I-Outcome
during -X- _ I-Outcome
the -X- _ I-Outcome
relapse -X- _ I-Outcome
of -X- _ I-Outcome
neuromyelitis -X- _ I-Outcome
optica. -X- _ I-Outcome
Notably -X- _ O
, -X- _ O
these -X- _ O
CD138 -X- _ O
( -X- _ O
+ -X- _ O
) -X- _ O
HLA-DR -X- _ O
( -X- _ O
+ -X- _ O
) -X- _ O
plasmablasts -X- _ O
overexpress -X- _ O
CXCR3 -X- _ O
, -X- _ O
whose -X- _ O
ligands -X- _ O
are -X- _ O
present -X- _ O
in -X- _ O
the -X- _ O
cerebrospinal -X- _ O
fluid -X- _ O
during -X- _ O
the -X- _ O
relapse -X- _ O
of -X- _ O
neuromyelitis -X- _ O
optica. -X- _ O
These -X- _ O
results -X- _ O
led -X- _ O
us -X- _ O
to -X- _ O
speculate -X- _ O
that -X- _ O
plasmablasts -X- _ B-Outcome
producing -X- _ I-Outcome
anti-aquaporin -X- _ I-Outcome
4 -X- _ I-Outcome
autoantibodies -X- _ I-Outcome
might -X- _ I-Outcome
traffic -X- _ I-Outcome
toward -X- _ I-Outcome
the -X- _ I-Outcome
central -X- _ I-Outcome
nervous -X- _ I-Outcome
system -X- _ I-Outcome
( -X- _ I-Outcome
CNS -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
Furthermore -X- _ O
, -X- _ O
we -X- _ O
performed -X- _ O
single-cell -X- _ O
sorting -X- _ O
of -X- _ O
plasmablasts -X- _ O
from -X- _ O
peripheral -X- _ O
blood -X- _ O
and -X- _ O
CSF -X- _ O
samples -X- _ O
from -X- _ O
NMO -X- _ O
and -X- _ O
sequenced -X- _ O
the -X- _ O
complementarity- -X- _ O
determining -X- _ O
regions -X- _ O
( -X- _ O
CDRs -X- _ O
) -X- _ O
of -X- _ O
the -X- _ O
IgG -X- _ O
heavy -X- _ O
chain -X- _ O
expressed -X- _ O
by -X- _ O
the -X- _ O
sorted -X- _ O
plasmablast -X- _ O
clones. -X- _ O
There -X- _ O
were -X- _ O
high -X- _ O
frequencies -X- _ O
of -X- _ O
mutations -X- _ O
in -X- _ O
the -X- _ O
CDRs -X- _ O
compared -X- _ O
with -X- _ O
framework -X- _ O
regions -X- _ O
, -X- _ O
indicating -X- _ O
that -X- _ O
these -X- _ O
plasmablast -X- _ O
clones -X- _ O
would -X- _ O
represent -X- _ O
a -X- _ O
post-germinal -X- _ O
center -X- _ O
B-cell -X- _ O
lineage. -X- _ O
Consistent -X- _ O
with -X- _ O
the -X- _ O
preceding -X- _ O
results -X- _ O
, -X- _ O
the -X- _ O
plasmablast -X- _ B-Outcome
clones -X- _ I-Outcome
from -X- _ I-Outcome
the -X- _ I-Outcome
peripheral -X- _ I-Outcome
blood -X- _ I-Outcome
shared -X- _ I-Outcome
the -X- _ I-Outcome
same -X- _ I-Outcome
CDR -X- _ I-Outcome
sequences -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
clones -X- _ I-Outcome
from -X- _ I-Outcome
the -X- _ I-Outcome
CSF. -X- _ I-Outcome
These -X- _ O
results -X- _ O
indicate -X- _ O
that -X- _ O
IgG-producing -X- _ B-Outcome
plasmablasts -X- _ I-Outcome
, -X- _ I-Outcome
which -X- _ I-Outcome
are -X- _ I-Outcome
guided -X- _ I-Outcome
by -X- _ I-Outcome
helper -X- _ I-Outcome
T-cells -X- _ I-Outcome
, -X- _ I-Outcome
may -X- _ I-Outcome
migrate -X- _ I-Outcome
from -X- _ I-Outcome
the -X- _ I-Outcome
peripheral -X- _ I-Outcome
blood -X- _ I-Outcome
preferentially -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
CSF. -X- _ I-Outcome
Since -X- _ O
migratory -X- _ O
plasmablasts -X- _ O
could -X- _ O
be -X- _ O
involved -X- _ O
in -X- _ O
the -X- _ O
inflammatory -X- _ O
pathology -X- _ O
of -X- _ O
NMO -X- _ O
, -X- _ O
the -X- _ O
B-cell -X- _ O
subset -X- _ O
and -X- _ O
their -X- _ O
migration -X- _ O
might -X- _ O
be -X- _ O
an -X- _ O
attractive -X- _ O
therapeutic -X- _ O
target -X- _ O
. -X- _ O

